Related Experiment Video
Updated: Jun 21, 2026
Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
Published on: July 14, 2010
Amyloid-β1-42 oligomers compromise oligodendrocyte precursor cells and disrupt blood-brain barrier integrity in vitro
Masaru Toyokawa1, Ken Yasuda2, Akihiro Kikuya2
1Human Health Science, Graduate School of Medicine, Kyoto University, Japan; Department of Clinical Nursing, Shiga University of Medical Science, Japan.
Abstract:
Amyloid-β (Aβ), particularly the aggregation-prone Aβ1-42, plays a central role in Alzheimer's disease (AD). While its neuronal toxicity is well known, effects on glial and vascular cells remain unclear. To investigate how Aβ1-42 oligomers affect oligodendrocyte precursor cells (OPCs), pericytes (PCs), and endothelial cells (ECs), and how these effects contribute to blood-brain barrier (BBB) dysfunction. In vitro assays were used to assess cell viability and BBB integrity following Aβ exposure. Transcriptomic profiling was performed on Aβ1-42-treated OPCs. Transendothelial electrical resistance (TEER) was used to measure barrier function. Aβ1-42, but not Aβ1-40, induced cytotoxicity in OPCs and PCs. ECs showed impaired barrier function without cell death. Aβ1-42-treated OPCs upregulated pro-inflammatory genes (Mmp9, Il1b) and downregulated genes related to cell cycle and growth signaling. Conditioned media from Aβ-exposed OPCs and PCs reduced TEER in ECs, indicating paracrine-mediated BBB disruption. These findings demonstrate that Aβ1-42 oligomers impair BBB integrity under in vitro conditions through both direct and non-cell autonomous mechanisms. Further in vivo studies are warranted to validate the relevance of these mechanisms in AD pathogenesis.
Insights
Amyloid-beta 1-42 oligomers harm brain cells and disrupt the blood-brain barrier. This study reveals direct and indirect damage mechanisms, highlighting potential new Alzheimer's disease therapeutic targets.
Area of Science:
- Neuroscience
- Cell Biology
- Pathology
Background:
- Amyloid-beta (Aβ) aggregation, especially Aβ1-42, is central to Alzheimer's disease (AD).
- While Aβ's neurotoxicity is established, its impact on glial and vascular cells and the blood-brain barrier (BBB) is less understood.
Purpose of the Study:
- To investigate the effects of Aβ1-42 oligomers on oligodendrocyte precursor cells (OPCs), pericytes (PCs), and endothelial cells (ECs).
- To determine how these cellular effects contribute to BBB dysfunction in vitro.
Main Methods:
- In vitro assays assessed cell viability and BBB integrity after Aβ exposure.
- Transcriptomic profiling analyzed Aβ1-42-treated OPCs.
- Transendothelial electrical resistance (TEER) measured BBB function.
Main Results:
- Aβ1-42, but not Aβ1-40, caused cytotoxicity in OPCs and PCs.
- ECs exhibited impaired barrier function without cell death.
- Aβ1-42-treated OPCs showed altered gene expression, including upregulation of inflammatory genes (Mmp9, Il1b) and downregulation of cell cycle genes.
- Conditioned media from Aβ-exposed OPCs and PCs reduced EC TEER, indicating paracrine signaling contributes to BBB disruption.
Conclusions:
- Aβ1-42 oligomers impair in vitro BBB integrity via direct and non-cell autonomous mechanisms.
- These findings suggest Aβ1-42's role in BBB dysfunction involves glial and vascular cell interactions.
- Further in vivo studies are needed to confirm these mechanisms in Alzheimer's disease pathogenesis.
More Related Videos
Related Concept Videos
03:03Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:23Alzheimer Disease ll: Pathophysiology